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BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder and assessment of 
newborns with or without this deficiency is an essential component in public health evaluation in different 
countries. Hence, this study was aimed to assess the prevalence of G6PD deficiency in the newborn population in 
Sanandj, Iran.  
METHODS: This is a cross-sectional study on 2016 newborns in Besat Hospital in Sanandaj, Iran, in the year 2006. 
Three drops of blood were collected from the infants’ heels using sterile needles. Then fluorescent spot test was 
utilized to study the activity of G6PD enzyme. 
RESULTS: The results of the present study conducted on 2016 neonates showed that 48.80% (984) of them were 
males and 51.20% (1032) were females. Prevalence of G6PD deficiency in boys and girls were 7.62% and 2.52%, 
respectively with a male to female ratio of 3:1. 
CONCLUSION: G6PD deficiency is a gender related condition with a higher frequency among boys’ population. 
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Introduction1 
Glucose-6-phosphate dehydrogenase (G6PD) is a 
universally common hereditary disorder. 
According to World Health Organization (WHO) 
reports, 2.9% of the world population and  
10-15% of the Iranians have G6PD deficiency.1,2 
This disease is more prevalent in Africa, Asia, the 
Mediterranean, and the Middle East, and 
approximately 200-400 million people suffer 
from it all over the world.3,4 
G6PD enzyme exists in all cells and has a 
crucial role in providing cell protection during 
oxidative stress.5 In individuals with G6PD 




deficiency, lifetime of these cells is lower than 
normal due to oxidation of red blood cell 
membrane; therefore, hemolysis occurs. 
Moreover, excessive red cell hemolysis and 
increased catabolism raise blood bilirubin and 
jaundice.6 
Main symptoms of defect in G6PD enzyme 
include acute hemolytic anemia and classic 
appearance of favism, neonatal jaundice, and 
non-spherocytic hemolytic anemia.7 Neonatal 
jaundice is one of the most important and 
remarkable symptoms of this deficiency.8 An 
important problem of hyperbilirubinemia is 
irreversible neurological complications and 
profound mental retardation in the newborns, 
which are highly prevalent in Greek, Nigeria, 
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with this deficiency cannot be blood donators. 
Moreover, prolonged contact with mild cell 
hemolytic individuals can cause chronic 
anemia.10 
Identifying neonates with this enzyme 
deficiency is highly significant. Different studies 
from around the world have considered 
screening of neonates regarding G6PD enzyme 
as a very effective factor in decreasing 
Kernicterus. Recent studies on health education 
in ethnic Kurds revealed a high prevalence of 
this medical and health risk factors.11-13 
However, few studies have been conducted on 
G6PD in ethnic Kurds as one of the Iranian 
ethnicities and prevalence of the disease in 
Sanandaj, Iran, has not been identified yet; 
therefore, detection of the disease would help 
reduction of side-effects by consuming food and 
medication containing antioxidants. Hence, the 
present study was aimed at identifying prevalence 
of G6PD dehydrogenase deficiency in neonates in 
Sanandaj. 
Materials and Methods 
This is a cross-sectional study conducted on 2016 
neonates born in Besat Hospital in Sanandaj from 
2006 to 2007. Permissions were obtained from 
neonates’ parents. Then three drops of blood 
collected from the infants’ heels using sterile 
needles after recording of the infants’ 
characteristics. 
Fluorescent spot test was utilized to study 
the activity of G6PD enzyme. For this 
purpose, 100 µl of reagent put in a small 
container and 10 µl of whole blood containing 
ethylenediaminetetraacetic acid were taken from 
the neonates’ feet which was added and mixed 
afterwards. Subsequently, the solution was kept 
at the room temperature for 20 min, a drop was 
taken from it using a 20-µl sampler and put on 
the filter paper. Then the paper was left out to 
dry. The resulted spot was put under fluorescent 
light with the wavelength of 365 µm and its 
reflected light studied, then the collected data 
were registered. Samples with G6PD enzyme 
had the ability to catalyze the chemical reaction, 
reflect the fluorescent light, and turned into 
green; however, those with G6PD enzyme 
deficiency turned into black and could not reflect 
the light. Data were analyzed in SPSS for 
Windows (version 16.0, SPSS Inc., Chicago, IL, 
USA) using chi-square and odds ratio (OR). 
Results 
The present study conducted on 2016 neonates 
including 984 (48.80%) males, and 1032 (51.20%) 
females. Prevalence of G6PD dehydrogenase 
deficiency was 5.00%, 7.62% in male infants and 
2.52% in female. The ratio of male to female in 
this particular enzyme was 3.02, in addition, chi-
square test proved a statistically significant 
relationship between G6PD dehydrogenase 
deficiency and neonates’ sex (P = 0.0001). The OR 
was 3.19 (confidence interval 1.98-5.17) (Table 1). 
 
Table 1. Relationship between sex and glucose-6-
phosphate dehydrogenase deficiency, in the male and 
female newborns of Sanandaj, Iran 
Sex With G6PD deficiency, n (%) 
Without G6PD 
deficiency, n (%) 
Male 75 (74.3) 909 (47.5) 
Female 26 (25.7) 1006 (52.5) 
Total 101 (100) 1915 (100) 
G6PD: Glucose-6-phosphate dehydrogenase 
Discussion 
G6PD dehydrogenase deficiency is a sex-related 
disorder and has different prevalence rates in 
different countries. In the present study, 
prevalence of G6PD dehydrogenase deficiency 
was 5.0%. Its level of prevalence varies in 
different regions of the country. It has been 
reported to be 19.3% in Southeastern Iran,14 
10.9% in Mazandaran,15 7.5% in Isfahan,16,17 3.2% 
in Tehran,18 and 2.1% in Zanjan.19 In a similar 
study conducted in Rafsanjan by Alidalaki, 
G6PD prevalence was 5.0%.10 Prevalence of 
G6PD dehydrogenase deficiency was 25.0% in 
Oman,20 and 22.0% in Nigeria;21 despite a lower 
rate of prevalence of 5.0% and 3.0% in Canada 
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prevalence in Sanandaj compared to other 
countries in the world is in the middle. In 
addition, due to differences in level of prevalence 
in different parts of Iran from one side and 
different countries on the other side, it could be 
concluded that factors such as race, geographical 
conditions, and weather are responsible for the 
differences in the number of affected cases. 
Prevalence of G6PD dehydrogenase 
deficiency in boys and girls were 7.62% and 
2.52%, respectively with a male to female ratio of 
3:1. In Kazemi et al. study, female population 
outnumbered the disease cases.18 In a study 
conducted by Khalesy et al., boys suffered from 
G6PD dehydrogenase deficiency 5 times more 
than girls.24 In Alidalaki et al. study, there was no 
significant difference between boys and girls 
regarding the incidence of the disease.10 In a 
study conducted in Mazandaran by Ahmadi and 
Ghazizadeh, it was reported that the incidence of 
the disease in boys were 3 times more than 
girls.25 
Due to sex-related nature of G6PD enzyme 
deficiency, in different parts of Iran, especially 
where the disease incidence among girls and boys 
is the same, differences in levels of prevalence in 
the two sexes is likely to be related to regional and 
racial factors. However, it is necessary to conduct 
related studies further on a larger scale targeting 
all over Iran. Therefore, it is recommended to 
screen, especially cord blood of male infants right 
after birth. It is also recommended that further 
national studies on the prevalence of G6PD 
enzyme deficiency be conducted. 
Conclusion 
Prevalence of G6PD dehydrogenase deficiency 
was 5.00%, 7.62% in male infants and 2.52% in 
female in Sanandaj. Therefore, G6PD 
dehydrogenase deficiency is a gender related 
condition with a higher frequency among boys’ 
population. 
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